Insulin and pentastarch for severe sepsis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  New England Journal of Medicine

• Publication date

  2008-05-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMc080223PMID 18463387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Glycemic control in sepsis and septic shock: friend or foe?].

  2008cited by this paper
• Chimerism and tolerance in a recipient of a deceased-donor liver transplant.

  2008cited by this paper
• Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

  2008cited by this paper
• Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

  2007cited by this paper
• [The design of the VISEP trial. Critical appraisal].

  2007cited by this paper
• Long-term effect of diabetes and its treatment on cognitive function.

  2007cited by this paper
• Long-term effect of diabetes and its treatment on cognitive function

  2007cited by this paper
• Predictors of Postoperative Acute Renal Failure after Noncardiac Surgery in Patients with Previously Normal Renal Function

  2007cited by this paper
• Intensive Insulin Therapy in the Medical ICU

  2007cited by this paper
• Management of Venous Thromboembolism

  2007cited by this paper
• Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization

  2007cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006cited by this paper
• Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units

  2006cited by this paper
• Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials.

  2006cited by this paper
• Studienprotokoll der VISEP-Studie

  2006cited by this paper
• Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis.

  2006cited by this paper
• Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.

  2006cited by this paper
• Treatment of an infant with X‐linked severe combined immunodeficiency (SCID‐X1) by gene therapy in Australia

  2005cited by this paper
• Human hematopoietic stem/progenitor‐enriched CD34+ cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction

  2005cited by this paper
• Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?

  2002cited by this paper
• The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment

  2002cited by this paper
• Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

  2001cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper

• Evidence-based fluid management in the ICU

  2016cites this paper
• Hyperglycemia in the Surgical Intensive Care Unit

  2016cites this paper
• Hydroxyethyl starch in sepsis.

  2014cites this paper
• Fluid therapy in critical illness: a special focus on indication, the use of hydroxyethyl starch and its different raw materials.

  2013cites this paper
• Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

  2013cites this paper
• Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients

  2013cites this paper
• Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients - a multidisciplinary statement

  2013cites this paper
• Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease.

  2012cites this paper
• Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?

  2011cites this paper
• Volumentherapie in der Intensivmedizin

  2011cites this paper
• Perioperative Glycemic Control: An Evidence-based Review

  2009cites this paper
• Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients

  2009cites this paper
• Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients

  2009cites this paper
• NICE-SUGAR, bittersweet

  2009cites this paper
• Management of Inpatient Hyperglycemia: A Systematic Review

  2008cites this paper